Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy

MLA

Ali F. Abdel-Wahab, et al. “Renal Protective Effect of SGLT2 Inhibitor Dapagliflozin Alone and in Combination with Irbesartan in a Rat Model of Diabetic Nephropathy.” Biomedicinepharmacotherapy = Biomedecinepharmacotherapie, vol. 103, Feb. 2018. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3fa2eb91d0f3cb023c9cbce1671e1708&authtype=sso&custid=ns315887.

APA

Ali F. Abdel-Wahab, Naser A. ElSawy, Ghazi A. Bamagous, Saeed S. Al Ghamdi, Ibrahim Abdel Aziz Ibrahim, Naiyer Shahzad, & Randa M. Al-Harizy. (2018). Renal protective effect of SGLT2 inhibitor dapagliflozin alone and in combination with irbesartan in a rat model of diabetic nephropathy. Biomedicinepharmacotherapy = Biomedecinepharmacotherapie, 103.

Chicago

Ali F. Abdel-Wahab, Naser A. ElSawy, Ghazi A. Bamagous, Saeed S. Al Ghamdi, Ibrahim Abdel Aziz Ibrahim, Naiyer Shahzad, and Randa M. Al-Harizy. 2018. “Renal Protective Effect of SGLT2 Inhibitor Dapagliflozin Alone and in Combination with Irbesartan in a Rat Model of Diabetic Nephropathy.” Biomedicinepharmacotherapy = Biomedecinepharmacotherapie 103 (February). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3fa2eb91d0f3cb023c9cbce1671e1708&authtype=sso&custid=ns315887.